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A convenient way to study lipid oxidation products-modified proteins by means of suitable
model systems has been investigated. As a model peptide, the oxidized B chain of insulin has
been chemically modified by either 4-hydroxy-2-nonenal (HNE) or hexanal and the extent,
sites, and structure of modifications were assessed by electrospray mass spectrometry. A
reduction step, using either NaCNBH3 or NaBH4, was also studied to stabilize the alkylated
compounds. From the data gathered, it appeared that NaCNBH3, when added at the beginning
of incubation, dramatically influenced the HNE-induced modifications in terms of the addition
mechanism (Schiff base formation instead of Michael addition) but also of the amino acid
residues modified (N-terminal amino acid instead of histidine residues). However, by
reducing the HNE-adducted species at the end of the reaction with NaBH4, the fragment ions
obtained in the product ion scan experiments become more stable and thus, easier to interpret
in terms of origin and mechanism involved. With regard to hexanal induced modifications, we
have observed that hexanal addition under reductive conditions led to an extensive modifi-
cation of the peptide backbone. Moreover, as confirmed by “in-source” collision followed by
collision induced dissociation (CID) experiments on selected precursor ions (pseudo-MS3
experiments), N,N-di-alkylations were first observed on the N-terminal residue and further on
Lys29 residue. On the other hand, compared to the native peptide, no significant changes in
MS/MS fragmentation patterns (b and y ions series) were observed whatever the basic site
modified by the aldehyde-addition. (J Am Soc Mass Spectrom 2003, 14, 215–226) © 2003
American Society for Mass Spectrometry
Lipid oxidation is a major cause of quality deteri-oration during the processing/storage of lipid-rich foods, thus limiting their shelf-life stability.
Hydroperoxides, the primary products of lipid oxida-
tion, are colorless, tasteless and odorless. The break-
down products of these peroxides yield a complex
mixture of low molecular weight compounds with
distinctive odor and flavor characteristics, including
alkanes, alkenes, aldehydes, ketones, alcohol, esters,
and acids [1, 2]. Among all these oxidation products,
aldehydes belong to the most important off-flavor com-
pounds of rancidic fats and oils. Low molecular alka-
nals, (hydroxy) alkenals and alkadienals are known to
readily react with nucleophilic residues of food proteins
[3, 4]. Such chemical modifications represent an impor-
tant deteriorative mechanism in the processing and
storage of foods causing loss in color, flavor, function-
al/physical properties and nutritive values [5]. More-
over, in biological systems, numerous disease states
(cancer, cardiovascular disease,. . .) have been associ-
ated with lipid-modified proteins [6, 7].
Therefore, these reactions and interactions are of
high interest in food science as well as in other disci-
plines. As described earlier, aldehydes are able to react
with nitrogenous nucleophiles such as lysine, histidine,
or cysteine to form Schiff bases (imines) whereas alk-
enals and hydroxy-alkenals could also undergo Michael
(1–4) addition (Figure 1) [7–11]. Among these different
lipid oxidation products, 4-hydroxy-2-nonenal (HNE)
has received particular attention and was found to
occur mainly on histidine or lysine residues via a
Michael addition [8, 12–14]. Indeed, Bruenner et al.
have reported the mass spectrometric analysis of two
HNE-modified model proteins (-lactoglobulin B and
human hemoglobin) and thus showed, by comparison
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of the molecular masses, the preponderance of the
Michael addition over the Schiff base condensation
[7]. Moreover, the histidine residues were identified
as the main target of HNE modification in human
hemoglobin as well as -lactoglobulin B [7], apomyo-
globin [14], or subunit VIII of bovine heart cyto-
chrome c oxidase [12]. In contrast, lysine residues
seem to be the predominantly HNE-modified resi-
dues in glucose-6-phosphate dehydrogenase [15, 16].
To our knowledge, the literature does not report
some dramatic changes in CID fragmentation pat-
terns (b or y fragment ions series) when proteins are
modified by HNE as well as by other aldehydes
originating from lipid oxidation.
Depending on both the aldehyde and amino acid
considered, the modified residues could exhibit a pro-
pensity to hydrolysis, thus making necessary their
reduction to the corresponding stable secondary amine
or alcohol prior to analysis. For obtaining stable alde-
hyde-modified proteins or peptides, reductive alkyla-
tion conditions are often employed by incubating the
substrates in the presence of sodium cyanoborohydride
(NaCNBH3) under alkaline pH conditions to reduce the
imines immediately upon formation without reducing
unreacted aldehydes. Such approach has previously
been used to evaluate the extent, site, structure and
potential changes in physical and/or nutritional prop-
erties of proteins modified by aldehydes or aldoses
[16–18] as well as to synthetize antigens for further
antibody production [19]. As an alternative, sodium
borohydride (NaBH4) could also be used at the end of
the reaction [8, 20, 21]. Under slightly alkaline condi-
tions, this reagent will lead to the reduction of both the
modified amino acid residues (unlike Schiff base and
Michael adducts) and the remaining unreacted alde-
hydes, thus acting as a reaction quencher [22]. The
reduced modified residues exhibit improved stability
since they are resistant to acid hydrolysis conditions
(HCl 6N at 110 °C during 20–24 h) [8, 21]. Therefore, a
reductive stabilization is of high interest if an acid-
driven cleavage of proteins is envisioned to quantify the
extent of such modifications.
The goal of this work was to identify and to further
characterize by electrospray ionization mass spectro-
metry (ESI-MS) and MS/MS experiments the protein
modifications formed upon aldehyde treatment. More-
over, we have also investigated the utilization of reduc-
tive stabilization and its influence in terms of chemical
and gas phase ion behavior. For such purpose, we have
studied the chemical modifications of a model peptide
(oxidized insulin B chain) by two different aldehydic
compounds: (1) 4-hydroxy-2-nonenal, a cytotoxic hy-
droxyalkenal often measured as indicator of in vivo
oxidative stress [8, 23] and (2) hexanal, which is com-
monly recognized as a marker of food quality [1, 19, 24].
Figure 1. Mechanisms for the formation and stabilization of the HNE Michael and Schiff base
adducts.
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Experimental
Materials
Oxidized insulin B chain and octanal were obtained
from Sigma (Bu¨chs, Switzerland). Hexanal, sodium
cyanoborohydride, and sodium borohydride were pur-
chased from Aldrich (Bu¨chs, Switzerland) whereas bu-
tanal was from Fluka (Bu¨chs, Switzerland). Finally,
4-hydroxy-2-nonenal was obtained from Alexis
(Laufelfingen, Switzerland). All other chemical reagents
were of analytical or HPLC grade.
Sample Preparation
Oxidized insulin B chain (58 M, M 3495.9 Da) was
incubated overnight at 37 °C in an aqueous solution of
0.3 mM HNE or 2.8 mM saturated aldehydes (butanal,
hexanal, and octanal) buffered with 50 mM phosphate
buffer pH 7.4 (final volume, 0.5 ml). These experiments
were performed both in the absence and in the presence
of NaCNBH3 (20 mM in phosphate buffer). For NaBH4
reduction, 100 l of a 0.1 M solution in 0.1 N NaOH
were added at the end of the incubation and the
mixtures were further incubated for 1 h at 37 °C. After
cooling down at room temperature, the resulting mod-
ified peptides were purified/desalted chromatographi-
cally on a reusable reverse phase cartridge (Peptide
Macrotrap, Michrom Bioressources, Pleasanton, CA).
The cartridge was washed with 0.1% acetic acid and the
peptides were recovered by elution with 200 l of
methanol/water (80:20, vol/vol) containing 0.1% acetic
acid.
Mass Spectrometry
MS analyses were performed on a TSQ 7000 mass
spectrometer equipped with an API 2 interface in
positive electrospray ionization mode (ThermoFinni-
gan, San Jose, CA). The spray voltage was set at 4.0 kV
with a capillary temperature of 250 °C and a sheath gas
(nitrogen) pressure of 80 psi. After elution from the
desalting Macrotrap peptide cartridge, the peptides
mixture was infused at a flow rate of 3 l/min into the
ESI source using a syringe pump (Harvard Apparatus,
South Natick, MA). Full scan positive mass spectra
were recorded by scanning a m/z range of 500–2000
(mass unit resolution) with a scan time of 2 s. Low
energy CID experiments were achieved on multiply
charged species at different collision energies (ELab
20–45 eV), using argon as collision gas at a pressure of
2.8 mTorr (1 torr  133.3 Pa). Moreover, for the CID
experiments performed after “in-source” collision
(pseudo-MS3) [25], a voltage of 50–70 V was applied to
the octapole (in-source) to generate unspecific primary
fragment ions that were then selected in the first quad-
rupole and further collisioned with argon (pressure of
2.8 mTorr, ELab 20–30 eV) in the second quadrupole.
Typically, mass spectra and CID spectra were accumu-
lated into a single data file for 1–5 min. Data processing
was performed using the Finnigan Xcalibur software.
Results and Discussion
HNE-Modified Oxidized Insulin B Chain
Oxidized insulin B chain was chosen as model peptide
because it contains four basic residues (His5, His10,
Arg22, and Lys29) plus the N-terminal. The two cysteine
residues are blocked as cysteic acids, avoiding the
possibility of dimerization or peptide aggregation (pep-
tide sequence is represented in Figure 2). Figure 2
summarizes the adducts formed after incubating the
peptide with HNE in the presence and in the absence of
reductive agent (i.e., NaCNBH3 or NaBH4).
When oxidized insulin B chain was simply reacted
with HNE, two adducts corresponding to a mass in-
crease of 156 u were observed (M 3652.0 and 3808.0 Da).
The appearance of such mass increments confirms the
addition of two HNE moieties via a Michael mechanism
(Figure 1). To identify the sites of modification, CID
experiments were performed on the respective triply
charged categories of these two HNE-adducted species
(i.e., m/z 1218.3 and 1270.3). Modified fragment ions are
labeled with an asterisk and according to the nomen-
clature of peptide fragmentation [26]. Thus, His5 was
the modified residue when the addition of only one
HNE molecule occurs, proven by the appearance of the
b5 ion containing one HNE moiety (Figure 3a), whereas
both His5 and His10 were found to be modified in the
case of di-alkylation (data not shown). As previously
described by Bolgar and Gaskell [14], HNE-modified
histidine residues give rise to an intense immonium ion
at m/z 266 (noted H*), thus confirming the presence of
an HNE molecule. Moreover, beside this typical immo-
nium ion, a fragment ion corresponding to the proton-
ated dehydrated HNE moiety can be clearly seen at m/z
139 in the product ion mass spectrum (Figure 3a). These
two typical fragment ions (m/z 139 and 266) observed in
such product ion scan analysis can be very helpful to
assess or confirm the presence of HNE-adducted pep-
tides, and consequently to characterize the involvement
of an histidine residue.
Likewise, a subsequent reduction by NaBH4 of the
different HNE-modified species, was performed to im-
prove their stability and also to confirm the identity of
the adducts obtained. Indeed, under slightly alkaline
conditions, either NaCNBH3 or NaBH4 effectively re-
duced the imine whereas only Michael adducts would
be sensitive to NaBH4 reduction [27]. In case of HNE
Michael adducts, this reduction step results in 158 u
mass increments (Figure 1). Figure 3b represents the
CID mass spectrum of the first reduced Michael adduct
obtained by selecting the triply charged species (m/z
1219.0). By reducing these HNE-adducted molecules at
the end of the alkylation reaction, the resulting modi-
fied fragment ions become more stable, thus easier to
localize the modification (cf. modified fragment ions
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labeled with an asterisk). Moreover, it should be noted
that NaBH4 reduction leads (1) to the formation of a
prominent reduced HNE histidine immonium ion at
m/z 268 (instead of m/z 266 in the absence of reduction)
and (2) to the disappearance of the protonated dehy-
drated HNE fragment ion previously observed at m/z
139. These differences regarding the observed fragment
ions demonstrate the HNE Michael adduct instability
(under non-reductive conditions) under our CID exper-
imental conditions. This feature has also been observed
by studying other HNE modified model peptides under
low energy collision-induced conditions. Thus, NaBH4
reduction appeared to modify the fragmentation behav-
ior of the HNE-His residue (Michael adduct) by stabi-
lization of the derivative and further suppression of the
loss of HNE moiety under the CID conditions used.
When oxidized insulin B chain was modified by
HNE under non reductive conditions, the HNE modi-
fication occurred predominantly by Michael addition
rather than Schiff base formation. On the contrary,
when NaCNBH3 is added at the beginning of the
incubation (to immediately reduce imines upon their
formation), a single adduct, differing by 140 u from the
native peptide (Figure 1), was observed (M 3636.1 Da)
and could be attributed to a reduced Schiff base HNE
adduct (Figure 2b). Moreover, this HNE adduct has
been characterized on the N-terminal Phe residue using
CID experiment by selecting the triply charged species
at m/z 1213.7 (Figure 3c). Among other discriminant
fragment ions, m/z 260 corresponds to the Phe (N-ter)
immonium ion modified by HNE via a Schiff base
mechanism. These results demonstrate that NaCNBH3
orientates the mechanism of HNE addition and thus,
changes the site(s) of modification. As a control exper-
iment, incubation of native oxidized insulin B chain was
performed with the reductive agent, which enabled to
verify the absence of side reaction products due the
native peptide itself (Figure 2c).
All the results gathered on HNE adduction revealed
that NaCNBH3 orientates the reaction toward the Schiff
base addition and also induces preferential modifica-
tion of the N-terminal residue (instead of histidine
residues in the absence of reducing agent). Moreover,
the comparison of the ESI mass spectra acquired on the
native oxidized insulin B chain and on the HNE-
modified species, revealed no significant difference
either in the observed charge states (2, 3, 4) or in
their relative abundances (data not shown). Therefore,
Figure 2. Deconvoluted ESI mass spectra of HNE-modified oxidized insulin B peptide chain
obtained under (a) normal and (b and c) reductive conditions. The peptide sequence has been
represented in the one letter code nomenclature.
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Figure 3. CID mass spectra of HNE-modified oxidized insulin B chain obtained by selecting the
triply charged species of (a) m/z 1218.3 for HNE modification without reducing agent, (b) m/z 1219.0
for HNE modification followed by NaBH4 treatment, and (c) m/z 1213.7 for HNE modification in the
presence of NaCNBH3. Modified fragment ions are labeled with an asterisk and according to the
nomenclature of peptide fragmentation [26].
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this type of adduct does not affect the protonation
orientation of this peptide during the ESIMS analysis.
Furthermore, the HNE modification of either the N-
terminal or histidine amino acid residues did not lead to
CID fragmentations fundamentally different, in terms
of ions distribution in b and y fragment ions series,
compared to the data previously obtained for the native
oxidized B chain of insulin. Therefore, HNE modifica-
tion does not seem to modify the proton transfer
occurring during the peptide fragmentation. It could be
assumed that a proton was not initially localized on the
His5 residue. In order to evaluate the histidine position-
ing influence on CID, Willard and Kinter have studied
a synthetic peptide containing one histidine in position
4 and suggested that both N-terminal and histidine
residues should be derivatized (with diethylpyrocar-
bonate) to observe significant changes in terms of CID
[28]. Therefore, it seems logical that the more significant
effects on CID will be observed for a higher number of
alkylated basic sites or on a folded protein.
In a second step, we have studied the effect of such
reductive alkylation on the saturated aldehydes addi-
tion to oxidized B chain of insulin, to assess its influence
when a single addition mechanism could occur (Schiff
base mechanism only).
Hexanal-Modified Oxidized Insulin B Chain
Figure 4 shows the deconvoluted ESI mass spectra of
oxidized insulin B chain treated with hexanal in absence
and presence of NaCNBH3. When no reductive agent
was added (Figure 4a), the major ions correspond to the
native peptide (M 3495.6 Da) in addition to one and two
hexanal-modified species (M 3577.5 and 3659.4 Da,
respectively). Some cationized sodium adducts were
also observed for the native peptide (M 3517.5 Da). CID
experiments were performed on the triply charged
species of the one and two hexanal-modified species
(i.e., m/z 1193.5 and 1220.8, respectively) and their
respective fragmentation patterns confirmed the attach-
ment of the aldehyde moieties to the N-terminal Phe1
and Lys29 residues, but predominantly on the N-termi-
nal (data not shown). Moreover, the observed relative
abundances of these two hexanal-adducted peptides
were rather low when compared to those of HNE-
modified species, thus underlining the poorer reactivity
of the saturated aldehydes in comparison to unsatur-
ated ones. However, incubation of hexanal performed
in the presence of NaCNBH3 resulted in a contrary
situation (Figure 4b). Indeed, this reagent seems to act
as a catalyst, thus generating up to four hexanal adducts
characterized by 84 u increments. The obtained decon-
voluted ESI mass spectrum apparently exhibits a rela-
tive distribution of the four adducted forms which
could be characteristic of a particular kinetic of addi-
tion. Actually, such trend could suggest that hexanal
modification occurs only on two distinct amino acid
residues.
Thus, CID experiments were performed on the re-
spective triply charged species (m/z 1222.5 and 1278.6)
(Figure 5). The CID spectra of the oxidized insulin B
chain modified by two and four hexanal moieties gave
rise to two couples of abundant ions observed at m/z
204.2, 288.3, and m/z 399.4, 483.5 (Figure 5a and b). The
first two fragment ions (i.e., m/z 204.2 and 288.3) could
be attributed to immonium ions of the N-terminal Phe1
bound with one and two hexanal moieties, respectively.
On the other hand, the second couple of ions observed
at m/z 399.4 and 483.5 were assigned to the y3 fragment
ions plus one and two hexanal moieties, respectively.
The occurrence of such mono- and di-alkylations is
totally conceivable since the reduction of the immo-
nium intermediate by BH3CN
 is a rapid reaction at pH
ca. 7.0 [29].
It has been previously reported in the literature that
low energy product ion spectra from a number of
peptides, obtained by “in-source” collision, were com-
parable in quality and information content with those
obtained by low energy CID in a quadrupole collision
cell [30–32]. Therefore, results from CID experiments
Figure 4. Deconvoluted ESI mass spectra of oxidized insulin B chain hexanal treated (a) in the
absence and (b) in the presence of NaCNBH3.
220 FENAILLE ET AL. J Am Soc Mass Spectrom 2003, 14, 215–226
performed on “in-source” generated ions would be
very similar to those obtained using a hybrid instru-
ment (BEQQ) or a pentaquadrupole [25, 33]. Thus, to
further confirm the presence of one and two hexanal
attachments at both N-terminal Phe1 and Lys29, “in-
source” collision followed by CID experiments were
Figure 5. CID spectra of hexanal-modified oxidized insulin B chain in the presence of NaCNBH3
obtained by selecting the triply charged species of (a) m/z 1222.5, and (b) m/z 1278.6, corresponding to
the addition of two and four hexanal molecules, respectively. Hexanal adducts have been abbreviated
by “hex”. “F  1 hex” and “F  2 hex” represent the N-ter Phe1 immonium ion modified by one and
two hexanal moieties, respectively.
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performed by selecting the corresponding ions. The
different fragment ions observed from the product ion
scan of m/z 288.3 (Figure 6) have been characterized and
clearly show the attachment of two hexanal moieties on
the N-terminal of Phe1. This CID spectrum exhibits two
losses of 70 u and 84 u (288.2 3 218.2, 288.2 3 204.2,
and 218.2 3 148.0, 218.2 3 134.1) characteristic of the
N,N-di-hexyl chains fragmentations. Figure 7a–c repre-
sent the “in-source” collision followed by CID analysis
of m/z 315.0, 399.3, and 483.5 corresponding to intact,
mono-alkylated- and di-alkylated y3 fragment ions (i.e.,
PKA peptidic chain), respectively. Interpretation of
these CID spectra confirms that N-mono-alkylation
and N,N-di-alkylation have occurred on the Lys29
residue (m/z 310.3 and 394.5 correspond to b2* and b2**,
respectively). Unfortunately, no characteristic immo-
Figure 6. CID spectra of hexanal-modified species obtained by selecting m/z 288.3 after “in-source”
collision.
Figure 7. CID spectra of hexanal-modified species obtained by selecting (a) m/z 315.3, (b) m/z 399.4,
and (c) m/z 483.5, after “ion-source” collision.
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nium ion of lysine-hexanal was observed. Moreover, as
already noted for the di-alkylation of Phe1, a loss of 70 u
was found for the b2*and b2** fragment ions (giving rise
to m/z 240.2 and 324.7, respectively), corresponding to a
partial loss of the hexyl chain. Finally, a loss of 71 u was
also observed for the three CID spectra giving rise to
fragment ions at m/z 244.0, 328.2, and 412.3 for the
native-, mono-alkylated- and di-alkylated-y3 CID spec-
tra, respectively. This typical loss on the C-terminus, in
this case Ala30, has already been reported in the litera-
ture and explained as resulting from a shift of the
hydroxyl group from the C-terminal carboxylic func-
tion [34–36]. Although this mechanism was first re-
ported under high collision energy (tandem sector
instrument), a similar pattern was observed here under
low collision energy conditions. The fragmentation
pathway (i.e., loss of 71 u) illustrated in Figure 8 for the
CID experiment of m/z 483.5 (di-alkylated PKA) is
similar for the native- and mono-alkylated-y3 ion spe-
cies.
The alkylation kinetic of hexanal towards oxidized
insulin B chain has then been evaluated under reductive
conditions. The hexanal modification in the presence of
NaCNBH3 is a rapid phenomenon since after 30 min, no
native peptide remains in the reaction mixture (Figure
9b). As previously underlined, Phe1 and Lys29 consti-
tute the alkylated sites. CID experiments performed on
the triply charged species of the different hexanal-
modified peptides (m/z 1194.2, 1222.2, 1250.2, and
1278.4) revealed that (1) the first hexanal molecule was
exclusively added to the N-terminal Phe1, (2) the dou-
bly modified peptide contained a mixture of di-alky-
lated Phe and mono-alkylated species of Phe and Lys
but no di-alkylated Lys residues, (3) the third modified
form was mainly di-alkylated on Phe1 and mono-
alkylated on Lys29 residue whereas (4) the last modified
peptide was di-alkylated on both Phe1 and Lys29 resi-
dues. These observations suggest that Lys29 is a less
reactive residue compared to Phe1, and thus corre-
sponds to the limiting factor of the hexanal alkylation
process. However, we can reasonably assume that the
tetra-alkylated peptide will be the only form observed
after a prolonged incubation period. On the other hand,
it should be noted that the same trend of alkylation was
also observed for butanal and octanal (Figure 10). In this
case, addition of butanal and octanal molecules to the
peptide leads to a mass increase of 56 and 112 u,
respectively. Moreover, when incubation of oxidized
insulin B chain is performed under competitive condi-
tions, i.e., with equimolar amounts of butanal, hexanal,
and octanal, several modified species resulting from the
different aldehydes were observed in similar ratios
(data not shown). These results give evidence that
neither competition nor alkyl chain length effects were
encountered, in the liquid phase, in the presence of
NaCNBH3. On the other hand, the same hexanal mod-
ifications were observed when bovine insulin (A and B
peptidic chains) was used as the model system instead
of oxidized insulin B chain.
Conclusions
The protein modifications generated by lipid oxidation
products have been investigated by studying the ad-
ducts formed upon reaction of a model peptide: Oxi-
dized insulin B chain and either HNE or hexanal. A
procedure for the stabilization of the different model
systems, by means of a reducing chemical agent (i.e.,
NaCNBH3 or NaBH4), has also been investigated. With
respect to HNE modification, it has been shown that
NaCNBH3, when added at the beginning of the incuba-
tion, dramatically modified the “natural” mechanism
involved in HNE addition. Indeed, NaCNBH3 appeared
to orientate the addition mechanism toward the imine
(Schiff base) formation (instead of Michael addition)
and thus, as shown by deconvoluted ESI mass spectra
Figure 8. Postulated fragmentation mechanism for the loss of
71 u from “in-source” collision followed by CID experiment
obtained by selecting m/z 483.5.
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to modify preferentially N-terminal amino acid rather
than the histidine residue. More interestingly, sample
reduction with NaBH4 reagent prior to analysis enabled
a better characterization of the HNE-modified species
due to an improved stability of the fragment ions under
low collision energy CID conditions, thus giving rise to
an intense diagnostic ion at m/z 268 (immonium ion of
modified histidine). Thus, screening for precursor ions
of m/z 268 can be applied to pull-out HNE-modified
peptides on histidine within a crude tryptic digest.
Furthermore, in a more global screening approach,
tandem mass spectrometry measurements could be
Figure 9. Deconvoluted ESI mass spectra of oxidized insulin B chain incubated with hexanal in the
presence of NaCNBH3 for 0, 0.5, 2, 4, 8, and 12 h.
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performed in precursor ion scan mode of m/z 139, which
corresponds to the protonated dehydrated HNE moi-
ety.
In light of hexanal adduction, NaCNBH3 could be
useful for increasing the modification degree of a model
peptide without orientating the alkylation toward a
certain type of amino acid residue (when oxidized
insulin B chain is used). However, the monitoring in
precursor ion scan mode of typical fragment ions re-
sulting from hexanal modifications has been assayed
but was rather unsuccessful. A more precise study of
the modified species by “in-source” collision followed
by CID experiments revealed that both N-terminal Phe1
and Lys29 residues were the targets of mono- and
further di-alkylation reactions. Due to its high effi-
ciency, this alkylation reaction should be placed under
control in order to obtain mono-alkylated model pep-
tides. Such approach could be useful to check if a lysine
lateral chain is involved in a certain mechanism or
fragmentation pathway.
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